Roche, Eli Lilly win FDA approval for Alzheimer's blood test
LLY Lilly(Eli) & Co
$1246.93 -0.67%
View chart & analysis → 
- 1Roche (RHHBY) and Eli Lilly (LLY) have secured FDA approval for the Alzheimer's blood test Elecsys pTau217.
- 2The test targets patients aged 55 and older showing cognitive decline and can be performed on more than 4,500 Roche analyzers across the United States.
- 3It offers greater accessibility than existing PET and cerebrospinal fluid tests, with Labcorp (LH) and Quest Diagnostics (DGX) planning to provide the test.
This 3-line summary is compiled from the report below.
InvestorsHub +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다